Home Cart Sign in  
Chemical Structure| 1092453-15-0 Chemical Structure| 1092453-15-0

Structure of AZD-8529
CAS No.: 1092453-15-0

Chemical Structure| 1092453-15-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

AZD-8529 is a potent, highly selective and orally bioavailable positive allosteric modulator of mGluR2, with an EC50 of 285 nM, and shows no positive allosteric modulator responses at 20-25 M on the mGluR1, 3, 4, 5, 6, 7, and 8 subtypes.

Synonyms: AZD-8529

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of AZD-8529

CAS No. :1092453-15-0
Formula : C24H24F3N5O3
M.W : 487.47
SMILES Code : O=C1N(CC2=CC=C(OC(F)(F)F)C=C2)CC3=C1C(C)=CC(C4=NC(CN5CCNCC5)=NO4)=C3
Synonyms :
AZD-8529
MDL No. :N/A

Safety of AZD-8529

Related Pathways of AZD-8529

GPCR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00921804 Schizophrenia Phase 2 Completed - United States, California ... More >> Research Site Garden Grove, California, United States Research Site Glendale, California, United States United States, Maryland Research Site Rockville, Maryland, United States Less <<
NCT00985933 Healthy Memor... More >>y Impairment Less << Early Phase 1 Completed - United States, Connecticut ... More >> Research Site New Haven, Connecticut, United States Less <<
NCT00886756 Healthy Phase 1 Completed - United Kingdom ... More >> Research Site London, United Kingdom Less <<
NCT00755378 Healthy Volunteer Phase 1 Completed - United States, Pennsylvania ... More >> Research Site Philadelphia, Pennsylvania, United States Less <<
NCT00986531 Schizophrenia Phase 1 Completed - United States, Pennsylvania ... More >> Research Site Philadelphia, Pennsylvania, United States Less <<
NCT02401022 Tobacco Use Disorder Phase 2 Completed - United States, California ... More >> Pharmacology Research Institute Encino, California, United States, 91316 Pacific Treatment and Research Center La Jolla, California, United States, 92037 Pharmacology Research Institute Los Alamitos, California, United States, 90720 Pharmacology Research Institute Newport Beach, California, United States, 92660 United States, Maryland University of Maryland - College Park College Park, Maryland, United States, 20742 United States, New York Columbia University Medical Center New York, New York, United States, 10019 United States, Ohio University of Cincinnati Cincinnati, Ohio, United States, 45229 United States, Pennsylvania Centers for the Studies of Addiction Philadelphia, Pennsylvania, United States, 19104 United States, Virginia Virginia Commonwelath University Richmond, Virginia, United States, 23219 Less <<
NCT02401022 - Completed - -
NCT00765492 Healthy Volunteer Phase 1 Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.05mL

0.41mL

0.21mL

10.26mL

2.05mL

1.03mL

20.51mL

4.10mL

2.05mL

 

Historical Records

Categories